Immunopathology of lentiviral infections in ungulate animals. NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Immunopathology of lentiviral infections in ungulate animals.

Curr Opin Immunol. 1989-90 Feb;2(3):399-402. Unique Identifier : AIDSLINE MED/90234249
Narayan O; Johns Hopkins University School of Medicine, Division of; Comparative Medicine, Baltimore, Maryland.

Abstract: The immunopathogenesis of lentiviral lesions in sheep and goats requires continuous replication of the virus in tissues of the animal. This entails escape from various defense mechanisms of the host. Viral expression occurs mainly in tissue-specific macrophage populations and viral proteins produced by the cells induce and combine with antibodies to form immune complexes. These may be pathogenic locally. Infected macrophages also present lentiviral antigens to T lymphocytes and this results in a cascade of cellular responses including proliferation and accumulation of CD8 cells. Cytokines including interferon(s) are produced by lymphocytes and these enhance the antigen-presenting capacity of the macrophages. These lymphoproliferative cellular responses vary from those in human immunodeficiency virus- and simian immunodeficiency virus-infected hosts, mainly because CD4 cells of sheep and goats are not killed by the viruses. These cells, therefore, respond immunologically to viral antigens and this leads to active-chronic inflammation.
Keywords: Animal Encephalitis/IMMUNOLOGY/PATHOLOGY/VETERINARY Equine Infectious Anemia/IMMUNOLOGY/PATHOLOGY Goat Diseases/IMMUNOLOGY/PATHOLOGY Goats Horses Macrophages/PATHOLOGY Pneumonia, Progressive Interstitial, of Sheep/IMMUNOLOGY/ PATHOLOGY Retroviridae/PHYSIOLOGY Retroviridae Infections/IMMUNOLOGY/PATHOLOGY/*VETERINARY Sheep Virus Replication JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL
900830
M9080707

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .